Testmate Health SA, alongside a consortium of R&D partners that include 3DUniversum and University Hospital of Geneva (HUG) are awarded a €1,37 million non-dilutive grant through the Eurostars Programme funded by the EUREKA countries and European Union.
Epalinges, 7th September 2022, Testmate Health SA, is an early stage Swiss start-up developing at home self-testing kits for common sexually transmitted diseases, enabled by digital health. Today, Testmate Health announced that alongside a consortium of R&D partners that include 3DUniversum and University Hospital of Geneva (HUG) are awarded a €1.37 million non-dilutive grant through the Eurostars Programme funded by the EUREKA countries and European Union.
This funding supports the product development towards clinical validation, the development of the app platform supported by AI, and further clinical validation at the University Hospital of Geneva. This collaboration will kick off on the 1st of October 2022.
